White & Case
This Institution’s articles
-
Raising the Global Bar for Security Clearance of Cross-border TransactionsDr. Tobias Heinrich, Marc Israel, Farhad Jalinous, Igor Ostapets, Veronica Pinotti, John Tivey, Jun Usami, Z. Alex Zhang, Orion Berg and Ksenia Tyunik, “Raising the Global Bar for Security Clearance of Cross-border Transactions” White & Case Publication (2018)
-
RPM Comes Back from the Dead- EU Commission Tackles Pricing in E-commerceJacquelyn MacLennan and Marc Israel, “RPM Comes Back from the Dead- EU Commission Tackles Pricing in E-commerce” White & Case Publications (July 2018)
-
Institutional Investors can Face Parental Liability in the EU, Just Like Other Corporate ParentsMark Powell, Axel Schulz and Jan Jeram, “Institutional Investors can Face Parental Liability in the EU, Just Like Other Corporate Parents” White & Case: Client Alert (July 2018)
-
Innovation in Merger ControlAxel Schulz, Matteo Giangaspero and Benoit Durand, “Innovation in Merger Control” White & Case Publications (May 2018)
-
Federal Constitutional Court Draws Formal Limits to the Prohibition of Seizure of Evidence on Lawyers’ PremisesJustus Herrlinger, Karl-Jörg Xylander and Alexander Kiefner, “Federal Constitutional Court Draws Formal Limits to the Prohibition of Seizure of Evidence on Lawyers’ Premises”, White & Case: Alert (July 2018)
-
Competition Appeal Tribunal Quashes the CMA’s Excessive Pricing Decision against Pfizer and Flynn PharmaJames Killick, Assimakis Komninos, Axel Schulz, Jan Jeram and Martin Möllmann, “Competition Appeal Tribunal Quashes the CMA’s Excessive Pricing Decision against Pfizer and Flynn Pharma” White & Case Publications (June 2018)
-
China Merges Antitrust Enforcement Agencies into One, as its Anti-monopoly Law Approaches 10th AnniversaryNoah Brumfield, J. Mark Gidley, Z. Alex Zhang and Yi Ying, “China Merges Antitrust Enforcement Agencies into One, as its Anti-monopoly Law Approaches 10th Anniversary” White & Case: Client Alert (March 2018)
-
Excessive Pricing in the Pharmaceutical Market – How the CAT Shot Down the CMA’s Pfizer/Flynn CaseExcessive Pricing in the Pharmaceutical Market – How the CAT Shot Down the CMA’s Pfizer/Flynn Case, James Killick, Assimakis Komninos, Journal of European Competition Law & Practice, 2018
